Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS , locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07

By Helbling D.   Bodoky G.   Gautschi O.   Sun H.   Bosman F.   Gloor B.   Burkhard R.   Winterhalder R.   Madlung A.   Rauch D.   Saletti P.   Widmer L.   Borner M.   Baertschi D.   Yan P.   Benhattar J.   Leibundgut E. O.   Bougel S.   Koeberle D.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 718-725

Oxford University Press

Access to resources Recommend Favorite

Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy

By                      

Oncology Reports, Vol. 28, Iss. 3, 2012-01 ,pp. : 855-861

Spandidos Publications

Access to resources Recommend Favorite

Upregulation of stromal cell-derived factor 1α expression is associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2493-2500

Spandidos Publications

Access to resources Recommend Favorite

Positron Emission Tomography Detection of Distant Metastatic or Synchronous Disease in Patients with Locally Advanced Rectal Cancer Receiving Preoperative Chemoradiation

By Nahas Caio  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1265-1265

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemoradiation Versus Hyperfractionated Accelerated Radiotherapy in Locally Advanced Rectal Cancer

By Ceelen Wim   Boterberg Tom   Pattyn Piet   Eijkeren Marc   Gillardin Jean-Marc   Demetter Pieter   Smeets Peter   Damme Nancy   Monsaert Els   Peeters Marc  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 424-431

Springer Publishing Company

Access to resources Recommend Favorite